ZerlasiranIntervention2 papersLatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 2Sep 2026: 0Oct 2026: 02Journal of Clinical LipidologyReview·17 hEfficacy and tolerability of targeted lipoprotein(a)-lowering therapies: A systematic reviewInterventionsAmerican Journal of Cardiovascular DrugsReview·1 SepLipoprotein(a): Cardiovascular Risk and Emerging Targeted TherapiesInterventions
Journal of Clinical LipidologyReview·17 hEfficacy and tolerability of targeted lipoprotein(a)-lowering therapies: A systematic reviewInterventions
American Journal of Cardiovascular DrugsReview·1 SepLipoprotein(a): Cardiovascular Risk and Emerging Targeted TherapiesInterventions